張 又升

Medicine & Life Sciences

1. Taiwan 100%
2. Systemic Lupus Erythematosus 93%
3. Population 58%
4. Cohort Studies 56%
5. Rheumatoid Arthritis 55%
6. Autoantibodies 39%
7. Autoimmune Diseases 36%
8. Sjogren's Syndrome 34%
9. Rheumatic Diseases 31%
10. Peptides 26%
11. Myasthenia Gravis 23%
12. National Health Programs 23%
13. Incidence 21%
14. Malondialdehyde 21%
15. Serum 20%
16. Confidence Intervals 19%
17. Tuberculosis 19%
18. Comorbidity 18%
19. Ankylosing Spondylitis 16%
20. Systemic Scleroderma 15%
21. Proportional Hazards Models 15%
22. Thymectomy 15%
23. Rheumatology 14%
24. Pneumocystis Pneumonia 14%
25. Epidemiology 13%
26. Databases 13%
27. Popliteal Cyst 12%
28. Internal Medicine 12%
29. Obstructive Sleep Apnea 11%
30. C1 peptide 11%
31. Proteomics 11%
32. Pancreatitis 11%
33. Infections 11%
34. lesinurad 11%
35. Autoimmune oophoritis 11%
36. Kidney Transplantation 11%
37. Hepacivirus 10%
38. 4-hydroxy-2-nonenal 10%
39. Osteoarthritis 10%
40. 2-nonenal 9%
41. Parkinson Disease 9%
42. Steroids 9%
43. inter-alpha-inhibitor 9%
44. Allergy and Immunology 9%
45. Virus Diseases 9%
46. Baths 9%
47. Thyroiditis 8%
48. Odds Ratio 8%
49. Bisphosphonate-Associated Osteonecrosis of the Jaw 8%
50. Meta-Analysis 8%